The Road to Recovery,    We are open.    We are clean.    We are ready.   Learn More!
School of Nursing | HNH Fitness | Villa Marie Claire | Simulation Learning | About Holy Name | Careers | Ways to Give

We are open.
We are clean.
We are ready.

Holy Name Medical Center is happy to announce that we have begun our return to normal operations. You may wonder, Is the hospital safe? Yes. We are ready. Ready to partner with you and your family on all your healthcare needs.

Holy Name is the first hospital in North Jersey to complete a rigorous, deep cleaning of our 450,000 square feet of clinical and non-clinical space. We started with manual disinfection, then applied electrostatic sanitizing mist, and finally, blasted UV-C light to kill more than 30 types of pathogens — including Covid-19.

Learn How Holy Name Became COVID-19 Clean

Now is a good time to think about your overall health and wellness. How can Holy Name help you?

View our services A-Z

Medical Care

Patients & Visitors

About Holy Name Medical Center About Holy Name Medical Center

Key Phone Numbers

  • Medical Center Operator

  • 201-833-3000

  • Physician Referral Service

  • 877-HOLY-NAME (465-9626)

  • Patient Information

  • 201-833-3300

  • Foundation (Donations)

  • 201-833-3187

  • Human Resources

  • 201-833-7040

  • Medical Staff Office

  • 201-833-3352

View All Department Contact Numbers

For general questions or comments, email

For More Information:

Gynecologic Oncology

Ovarian Cancer


Ovaries produce eggs for reproduction and are the main source of the female hormones estrogen and progesterone. They are located on either side of the uterus. There are typically three types of ovarian cancer: epithelial tumors, found in the outer surface of the ovary and the most common form of ovarian cancer; germ cell tumors, and stromal tumors.

Nearly 22,000 women in the U.S. are diagnosed annually with ovarian cancer. In the absence of a strong family or personal history with the disease, a woman’s chances of developing ovarian cancer are about 1 in 72 over the course of her lifetime, by the age of 70.

Ovarian cancer mainly occurs in older women. About half of those diagnosed are 63 years or older. It is more common in Caucasians than in African-American women.


Long known as the “silent killer,” ovarian cancer was thought to cause no symptoms during early stages of the disease. Studies have shown, however, that women with ovarian cancer frequently have repetitive and frequent symptoms but often feel the signs are caused by other illnesses or aren’t serious enough to warrant testing. Anyone with the following repetitive symptoms should speak to her health care provider:

  • Bloating

  • Pelvic or abdominal pain

  • Difficulty eating or feeling full too quickly

  • Urinary symptoms such as having to go urgently or frequently

  • Fatigue

  • Upset stomach or constipation

  • Back pain

  • Pain during sex

  • Menstrual changes

  • Abdominal swelling with weight loss


The causes of ovarian cancer are still unknown. Pregnancy and taking birth control pills lower the risk of the disease, so there may be a link between ovulation and ovarian cancer.

Risk Factors

  • Women with a mother, sister or daughter who had ovarian cancer.

  • Obese women, which means those with a body mass index of at least 30.

  • Women who have had breast cancer, particularly those who had it before they were 50 years old.

  • Women with certain mutated genes, for example, BRCA1 and BRCA2, as well as the damaged genes associated with Lynch Syndrome, among others. These mutated genes don't help suppress cell growth, making it easier for cancer to develop.

  • Women who took estrogen, without progesterone, after menopause for 10 or more years.

  • Infertile women.

  • Women who are middle-aged or older.

  • Talc

  • Asbestos

Tests and Diagnoses

Screenings are not typically effective for detecting ovarian cancer and should only be used for high-risk women until they have completed childbearing and are ready to have their fallopian tubes and ovaries removed.

  • A transvaginal ultrasound, performed with a wand in the vagina, uses sound waves to look at the uterus, fallopian tubes and ovaries. It typically finds masses but cannot distinguish between cancer and benign tumors.

  • A blood test to determine the level of CA-125, a protein found in the blood, can be used when a woman has already been diagnosed with ovarian cancer. The level is typically higher in women with the disease and the test can be effective in analyzing whether treatment is working. It is not used as a screening tool because other conditions can also raise the CA-125 level. In addition, not all women who have ovarian cancer have an elevated CA-125 level.

  • CT and MRI scans can detect a mass but cannot confirm if it is cancerous. A biopsy of tissue is necessary to confirm the diagnosis of ovarian cancer.


Ovarian cancer is most commonly treated with a combination of surgery and chemotherapy. Radiation is rarely used.

  • Surgery: Depending on the type of ovarian cancer, the stage of the disease, and the age of the patient, surgery may range from a full hysterectomy – removing both ovaries, fallopian tubes, uterus and cervix - to taking out just one ovary, which is done for fertility preservation, only when appropriate. In addition, when the disease is in an early stage, lymph nodes and biopsies of the tissue lining the abdomen are also removed to fully stage the cancer. When the disease is advanced, all visible signs of cancer are removed from the abdomen and pelvis.

  • Chemotherapy: Giving chemotherapy medications by mouth or injecting them into a vein has been the standard in cancer treatment for decades and is still used most often. But studies have shown that intraperitoneal chemotherapy, when the medication is inserted through a catheter directly into the abdominal cavity, results in better outcomes for many eligible women when battling ovarian cancer. Holy Name has been at the forefront in using this type of treatment. Dr. Sharyn Lewin, Director of Gynecologic Oncology, is one of the nation’s most skilled oncologists in advocating and utilizing intraperitoneal chemotherapy.

  • Targeted therapy is a treatment that uses drugs or other substances to alter the way a cancer cell grows, divides, repairs itself or interacts with other cells. Bevacizumab (Avastin) is one of these drugs and is often used to fight ovarian cancer. Personalized medicine allows such targeted therapy to treat cancer cells with the best chemotherapy drugs and new biologic agents available.


Aside from removing the ovaries and fallopian tubes, there is no way to prevent or screen for ovarian cancer.

The best prevention starts with knowing your family history. Women who are at high risk for developing the disease should undergo genetic testing (make this a link to our genetic testing page) and counseling. Those with a genetic predisposition have the highest risk for ovarian cancer and may have their ovaries and fallopian tubes removed to prevent the disease.

Women who use oral contraceptives lower their risk of developing the disease. If birth control pills are taken for five or more years, the chances of developing ovarian cancer are 50 percent lower compared to women who never used oral contraceptives. Oral contraceptives have side-effects and should be taken only after a full discussion with your physician.